{"entity":{"type":"insider","cik":"0001791244","url":"/insider/0001791244","json_url":"/insider/0001791244.json","name":"Robbins Wendye","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":56,"n_filings":18,"first":"2019-11-04","last":"2023-03-15","span_basis":"filed_date"},"name_variants":[{"name":"Robbins Wendye","source":"filing","n_filings":18,"first_seen":"2019-11-04","last_seen":"2023-03-15"}],"transactions":[{"id":8215417,"accession":"0001209191-23-019023","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-019023","line_url":"/filing/0001209191-23-019023","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":19.5224,"price_display":"19.52","price_state":"stated","total_value":97612.0,"total_display":"97,612.00","total_whole":"97,612","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider","n_lines":4},{"id":6460507,"accession":"0001593968-22-000958","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001593968-22-000958","line_url":"/filing/0001593968-22-000958","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":11.040285714285714,"price_display":"11.04","price_state":"stated","total_value":77282.0,"total_display":"77,282.00","total_whole":"77,282","shares_owned_after":13800.0,"shares_owned_after_display":"13,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider","n_lines":6},{"id":5472256,"accession":"0001593968-21-002279","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-21-002279","line_url":"/filing/0001593968-21-002279#line-1","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":30.7,"price_display":"30.70","price_state":"stated","total_value":15350.0,"total_display":"15,350.00","total_whole":"15,350","shares_owned_after":9300.0,"shares_owned_after_display":"9,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-19","scope":"insider"},{"id":5443020,"accession":"0001593968-21-002276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-21-002276","line_url":"/filing/0001593968-21-002276#line-1","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":29.69,"price_display":"29.69","price_state":"stated","total_value":11876.0,"total_display":"11,876.00","total_whole":"11,876","shares_owned_after":8800.0,"shares_owned_after_display":"8,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-15","scope":"insider"},{"id":4798607,"accession":"0001593968-21-002027","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001593968-21-002027","line_url":"/filing/0001593968-21-002027","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":525.0,"shares_display":"525","price_per_share":30.990952380952383,"price_display":"30.99","price_state":"stated","total_value":16270.25,"total_display":"16,270.25","total_whole":"16,270","shares_owned_after":1975.0,"shares_owned_after_display":"1,975","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-25","scope":"insider","n_lines":2},{"id":4798600,"accession":"0001593968-21-002027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-002027","line_url":"/filing/0001593968-21-002027","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1475.0,"shares_display":"1,475","price_per_share":31.386237288135593,"price_display":"31.39","price_state":"stated","total_value":46294.7,"total_display":"46,294.70","total_whole":"46,295","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider","n_lines":4},{"id":4333013,"accession":"0001593968-21-002007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002007","line_url":"/filing/0001593968-21-002007","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":29.5275,"price_display":"29.53","price_state":"stated","total_value":17716.5,"total_display":"17,716.50","total_whole":"17,717","shares_owned_after":8400.0,"shares_owned_after_display":"8,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-23","scope":"insider","n_lines":2},{"id":5077731,"accession":"0001593968-21-001818","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001818","line_url":"/filing/0001593968-21-001818","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":30.18,"price_display":"30.18","price_state":"stated","total_value":30180.0,"total_display":"30,180.00","total_whole":"30,180","shares_owned_after":7400.0,"shares_owned_after_display":"7,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-08","scope":"insider","n_lines":2},{"id":4109619,"accession":"0001593968-21-001661","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-001661","line_url":"/filing/0001593968-21-001661","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":705.0,"shares_display":"705","price_per_share":31.54190070921986,"price_display":"31.54","price_state":"stated","total_value":22237.04,"total_display":"22,237.04","total_whole":"22,237","shares_owned_after":6600.0,"shares_owned_after_display":"6,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-21","scope":"insider","n_lines":4},{"id":4576628,"accession":"0001593968-21-001115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001115","line_url":"/filing/0001593968-21-001115","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":19.457142857142856,"price_display":"19.46","price_state":"stated","total_value":13620.0,"total_display":"13,620.00","total_whole":"13,620","shares_owned_after":5800.0,"shares_owned_after_display":"5,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-14","scope":"insider","n_lines":2},{"id":4193310,"accession":"0001593968-21-001109","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001593968-21-001109","line_url":"/filing/0001593968-21-001109","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":21.074906285714285,"price_display":"21.07","price_state":"stated","total_value":29504.8688,"total_display":"29,504.87","total_whole":"29,505","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-09","filed_date":"2021-04-13","scope":"insider","n_lines":8},{"id":2873701,"accession":"0001593968-20-002236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-002236","line_url":"/filing/0001593968-20-002236","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":16.085,"price_display":"16.08","price_state":"stated","total_value":16085.0,"total_display":"16,085.00","total_whole":"16,085","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider","n_lines":2},{"id":2931402,"accession":"0001593968-20-001945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001945","line_url":"/filing/0001593968-20-001945","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":28.7,"price_display":"28.70","price_state":"stated","total_value":14350.0,"total_display":"14,350.00","total_whole":"14,350","shares_owned_after":6350.0,"shares_owned_after_display":"6,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-09-29","scope":"insider","n_lines":2},{"id":2620314,"accession":"0001593968-20-001939","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001593968-20-001939","line_url":"/filing/0001593968-20-001939#line-3","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":5600.0,"total_display":"5,600.00","total_whole":"5,600","shares_owned_after":6050.0,"shares_owned_after_display":"6,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-24","filed_date":"2020-09-24","scope":"insider"},{"id":2620311,"accession":"0001593968-20-001939","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001939","line_url":"/filing/0001593968-20-001939","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":29.199175,"price_display":"29.20","price_state":"stated","total_value":11679.67,"total_display":"11,679.67","total_whole":"11,680","shares_owned_after":5750.0,"shares_owned_after_display":"5,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-24","scope":"insider","n_lines":2},{"id":3046230,"accession":"0001209191-20-043778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043778","line_url":"/filing/0001209191-20-043778","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":22.47222222222222,"price_display":"22.47","price_state":"stated","total_value":20225.0,"total_display":"20,225.00","total_whole":"20,225","shares_owned_after":5050.0,"shares_owned_after_display":"5,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-24","filed_date":"2020-07-27","scope":"insider","n_lines":2},{"id":9292760,"accession":"0001593968-20-002048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001593968-20-002048","line_url":"/filing/0001593968-20-002048","is_derivative":false,"issuer_cik":"0001791244","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001791244","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":26.4,"price_display":"26.40","price_state":"stated","total_value":26400.0,"total_display":"26,400.00","total_whole":"26,400","shares_owned_after":4600.0,"shares_owned_after_display":"4,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-10-16","scope":"insider","n_lines":2},{"id":2111231,"accession":"0001209191-20-039899","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-039899","line_url":"/filing/0001209191-20-039899","is_derivative":false,"issuer_cik":"0001673772","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001673772","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":26.4,"price_display":"26.40","price_state":"stated","total_value":26400.0,"total_display":"26,400.00","total_whole":"26,400","shares_owned_after":4050.0,"shares_owned_after_display":"4,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-01","scope":"insider","n_lines":2},{"id":9292761,"accession":"0001593968-20-002048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002048","line_url":"/filing/0001593968-20-002048#line-1","is_derivative":false,"issuer_cik":"0001791244","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001791244","owner_cik":"0001791244","owner_name":"Robbins Wendye","owner_display_name":"Robbins Wendye","owner_url":"/insider/0001791244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1650.0,"shares_display":"1,650","price_per_share":26.02,"price_display":"26.02","price_state":"stated","total_value":42933.0,"total_display":"42,933.00","total_whole":"42,933","shares_owned_after":3600.0,"shares_owned_after_display":"3,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-10-16","scope":"insider"}],"collapsed":true,"next_cursor":"2020-06-29|9292761","ledger_fault":false,"count":{"value":56,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":56,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":56},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Director","n_filings":18,"first_seen":"2019-11-04","last_seen":"2023-03-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001791244","retrieved_at":"2026-08-23T04:47:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}